Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics

Salvatore Maria Corsello, Angelina Barini, Antonino Barbarino, Silvia Della Casa, Carlo Antonio Rota, Simonetta Colasanti, A Tofani, R Sciuto

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A paradoxical growth hormone (GH) response to thyrotropin-releasing hormone (TRH) has been observed in type 1 diabetic patients and was hypothetically attributed to a reduced hypothalamic somatostatin tone. We have previously reported that corticotropin-releasing hormone (CRH) inhibits GH response to growth hormone-releasing hormone (GHRH) in normal subjects, possibly by an increased release of somatostatin. To study the effect of CRH on anomalous GH response to TRH, we tested with TRH (200 micrograms intravenously [IV]) and CRH (100 micrograms IV) + TRH (200 micrograms IV) 13 patients (six males and seven women) affected by insulin-dependent diabetes mellitus. A paradoxical GH response to TRH was observed in seven of 13 patients, one man and six women. In these subjects, the simultaneous administration of CRH and TRH significantly reduced the GH response to TRH, as assessed by both the maximal GH mean peak +/- SE (2.18 +/- 0.67 v 9.2 +/- 1.26 micrograms/L, P less than 0.005) and the area under the curve (AUC) +/- SE (187 +/- 32 v 567 +/- 35 micrograms.min/L, P less than .001). CRH had no effect on TRH-induced thyroid-stimulating hormone (TSH) release. Our data demonstrate that the paradoxical GH response to TRH in patients with type 1 diabetes mellitus is blocked by CRH administration. This CRH action may be due to an enhanced somatostatin release. Our data also show that exogenous CRH has no effect on TSH response to TRH, thus suggesting the existence of separate pathways in the neuroregulation of GH and TSH secretion.
Original languageEnglish
Pages (from-to)949-953
Number of pages5
JournalMETABOLISM, CLINICAL AND EXPERIMENTAL
Volume41
Publication statusPublished - 1992

Keywords

  • Adult
  • Corticotropin-Releasing Hormone
  • Diabetes Mellitus, Type 1
  • Female
  • Growth Hormone
  • Humans
  • Injections, Intravenous
  • Male
  • Radioimmunoassay
  • Somatostatin
  • Thyrotropin
  • Thyrotropin-Releasing Hormone

Fingerprint

Dive into the research topics of 'Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics'. Together they form a unique fingerprint.

Cite this